ArticleJournal of orthopaedic surgery and research2025
Transcriptomic insights into the anti-apoptotic effect of Tuina in rabbit model of intervertebral disc degeneration.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From mechanotransduction to manual therapy: advances in piezo/TRP channels and lumbar degeneration.Frontiers in physiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTuina therapy is a promising treatment for spinal diseases, but its therapeutic mechanism remains poorly understood. Nucleus pulposus (NP) cell apoptosis is an important pathologic mechanism of intervertebral disc degeneration (IDD). We evaluated the intervention effect of sham-controlled placebo therapy on NP apoptosis in rabbit model of IDD and dissected the molecular mechanism by transcriptome analysis.
methodsIDD rabbit model was established by using intervertebral disc fibrous annulus puncture, and the intervention was carried out for 4 weeks in the Tuina group and the Placebo group. The intervention effects of the two therapies were assessed by H&E staining, MRI scanning, Tunel staining and flow cytometry. Transcriptome analysis was performed to detect key differentially expressed genes (DEGs) and related signaling pathways. The mRNA expression levels of key differentially expressed genes were verified by RT-qPCR.
resultsCompared with the Placebo therapy, the Tuina intervention was superior in inhibiting nucleus pulposus cell apoptosis and maintenance of disc morphology and structure. Protein-Protein Interaction (PPI) analysis showed that there were common differentially expressed genes among the Tuina, Placebo and Model groups. The mRNA expression of core signaling factors RPL17, LOC100354980 and LOC100339314 was consistent with the transcriptome sequencing results after the Tuina intervention, as verified by RT-qPCR.
conclusionOur results suggest that compared to Placebo therapy, Tuina intervention showed improved effects on tissue structural morphology and NP cell apoptosis. Tuina slowed down NP cell apoptosis in the rabbit model of IDD, which may be related to pathways such as Wnt, and the RPL17 gene may be a promising therapeutic target, and further studies are needed to elucidate their functional profile in IDD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.